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Ca2þ- and Thromboxane-Dependent Distribution of Functional MaxiK
Channels in Cultured Astrocytes
Jimmy W. Ou, Yogesh Kumar, Abderrahmane Alioua, Enrico Stefani,
Ligia Toro.
University of California at Los Angeles, Los Angeles, CA, USA.
Large-conductance, voltage- and Ca2þ-activated Kþ channels (MaxiK, BK) are
broadly expressed ion channels typically observed as a plasma membrane pro-
tein in various cell types. In murine astrocyte primary cultures, which are more
indicative of in-vivo reactive astrocytes rather than resting astrocytes, our pre-
vious results using high-resolution confocal microscopy have revealed the
novel finding that MaxiK pore-forming a subunit (MaxiKa) is distributed intra-
cellularly, colocalized along the microtubule network. This MaxiKa associa-
tion with microtubules was further confirmed by in vitro His-tag pulldown
assays, co-immunoprecipitation assays from brain lysates, and microtubule de-
polymerization experiments. Changes in intracellular Ca2þ elicited by general
pharmacological agents, caffeine (20mM) or thapsigargin (1mM), resulted in
increased MaxiKa labeling at the plasma membrane. More notably U46619,
a stable analog of thromboxane A2 (TXA2) which triggers Ca2þ-release path-
ways and whose levels increase during cerebral hemorrhage/trauma, also elicits
a similar increase in MaxiKa surface labeling. We now show using whole-cell
patch clamp recordings that U46619 stimulated cells develop a ~3-fold increase
in current amplitude. This data indicates that TXA2 stimulation results in the
recruitment of additional, functional MaxiK channels to the surface membrane.
These changes in MaxiKa plasma membrane distribution are effectively
blocked by preincubating astrocytes with a cell permeable Ca2þ-chelator,
BAPTA-AM, or by microtubule disruption prior to stimulation. While micro-
tubules are largely absent in mature astrocytes, our immunohistochemistry
results in brain slices show that cortical astrocytes in the developing newborn
mouse brain (P1) have a robust expression of microtubules that significantly
colocalize with MaxiKa. The results of this study provide the novel insight
that suggests Ca2þ released from intracellular stores, may play a key role in
regulating the traffic of intracellular, microtubule-associated MaxiKa stores
to the plasma membrane of reactive astrocytes. Supported by NIH.Voltage-gated Ca Channels I
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Membrane Voltage More Efficient In Closing Than Opening CaV1.2?
Stanislav Beyl1, Philipp Kuegler2, Michaela Kudrnac1, Annette Hohaus1,
Steffen Hering1, Eugen Timin1.
1Pharmacology and Toxicology, Vienna, Austria, 2Johann Radon Institute for
Computational and Applied Mathematics, Linz, Austria.
Point mutations in a gating-related sequence stretch in the pore-lining segment
IIS6 of CaV1.2 (779-782:LAIA motive) convert the high-voltage activated cal-
cium channel into a low-voltage activated one. Here we analyze the changes in
current activation and deactivation induced by these and glycine mutations in
this region. Our model describes channel activation as voltage-dependent sen-
sor movement and a voltage-independent pore opening and deactivation as
voltage-dependent return of the sensor and subsequent pore closure.
An inverse problem approach enabled the estimation of current activation and
deactivation rate constants from 16 mutants and wild type CaV1.2 with narrow
confidence intervals. Current activation, deactivation and steady-state activation
ofwild type and12mutants could befittedwith identical voltage dependencies of
the voltage sensing machinery
(x(V),y(V)). Steeper voltage de-
pendence of y(V) compared to
x(V) (see Figure) suggest that
a membrane hyperpolarisation
moreefficiently closes thanade-
polarization opens the channel.
Mutations in IIS6 of CaV1.2 de-
stabilizing the closed state si-
multaneously appear to stabilize
the open state in all 16 mutants.
* This study was supported by
a grant from FWF (Project
P19614-B11).932-Pos Board B811
Position Specificity of the Glycine Residues in IS6 of the L-type Cav1.2
Channel
Florian LeCoz, Alexandra Raybaud, Sebastien Wall-Lacelle,
Yolaine Dodier, Lucie Parent.Universite´ de Montre´al, Montreal, QC, Canada.
In the Timothy Syndrome (LQT8), mutations of the distal glycine residues in
IS6 severely delayed the inactivation kinetics of Cav1.2 (Splawski et al.,
2004, 2005). Our mutational analysis confirmed that Ala mutations of any
glycine within IS6 significantly decreased the inactivation kinetics (Raybaud
et al., 2006). To evaluate the position-specificity of these residues in IS6, we
performed a glycine scan of this region between S423 and E437
(NLVLGVLSGE). We hypothesized that introduction of a glycine residue at
neighboring positions within the LTQ8 mutants might rescue the Cav1.2 chan-
nel inactivation kinetics. Although S423G, F424G, and L434G yielded chan-
nels with slightly faster inactivation kinetics than the wild-type Cav1.2 channel,
the double mutants G422A/S423G and G422A/F424G failed to rescue the
channel normal inactivation kinetics. As G422 is located next to a bulky phe-
nylalanine residue, we aimed to evaluate the role of steric hindrance in control-
ling channel inactivation kinetics. F421G, F421A, F421W, as well as the
F421G/G422A double mutant have been characterized. Both F421A and
F421G behaved like the wild-type channel whereas F421W did not yield func-
tional currents. The double mutant F421G/G422F that switched the positions of
the wild-type Phe and Gly residues inactivated like the G422Amutant. Further-
more, permutations such as F421A/G422F and F421A/G422A also yielded the
G422A phenotype. Altogether, these experiments confirm the position-specific-
ity of the 3 glycine residues in IS6 in modulating the inactivation kinetics of
Cav1.2. In contrast, none of our mutations altered the voltage-dependence of
activation suggesting that residues in IS6 do not play a determinant role in
the activation properties of Cav1.2. Supported by the Heart and Stroke of Can-
ada and the Canadian Institutes of Health Research.
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Distinctive Inactivation Profiles of CaV1.2 Channels Encoding Different
Timothy Syndrome Mutations in Various Alternative Splicing Back-
grounds
Ivy E. Dick, Sarah A. Park, David T. Yue.
Johns Hopkins, Baltimore, MD, USA.
Timothy Syndrome is a CaV1.2 channelopathy, wherein mutations in the S6
segment of domain II affect channel inactivation. Interestingly, different muta-
tions (G402S or G406R) within alternatively spliced exons (8a or 8) entail char-
acteristic disease phenotypes, including autism, syndactyly, and long QT syn-
drome. Investigating Timothy Syndrome thereby promises mechanistic traction
into these complex outcomes. The prevalence and distribution of channels bear-
ing exon 8 versus 8a may explain some phenotypic variation. Here, we examine
such variation at a more fundamental level, resolving intrinsic differences of
inactivation among distinct mutant channels. Specifically, CaV1.2 inactivation
comprises two separate mechanisms, voltage-dependent inactivation (VDI),
and Ca2þ/calmodulin-mediated inactivation (CDI) (Barrett & Tsien PNAS
2008). Systematic mutagenesis of S6 domains in CaV1.3 suggest that VDI
and CDI alterations can be dissociated, and changes in channel activation are
likely (Tadross et al, this meeting). Our data here furnish remarkable examples
of differing CDI/VDI effects (a, wild-type, with Ba2þ current decay showing
VDI, and Ca2þ decay showing CDI; b, c, distinct CDI/VDI alterations). It
would be interesting if distinctive disease phenotypes and therapeutics ulti-
mately correspond to specified deficits of VDI, CDI, or both.934-Pos Board B813
Silencing of Cav1.2 gene in Rat Neonatal Cardiomyocytes by Lentiviral
delivered shRNA
Eddy Karnabi1, Yongxia Qu1, Natalia Grinkina1, Raj Wadgaonkar1,
Yunkun Yue2, Salvatore Mancarella3, Mohamed Boutjdir3.
1SUNY Downstate Medical Center, Brooklyn, NY, USA, 2VA Medical
Center, Brooklyn, NY, USA, 3SUNYDownstate Medical Center/VAMedical
Center, Brooklyn, NY, USA.
Background: Two types of L-type Ca Channels are expressed in the heart:
Cav1.2 (a1C) and Cav1.3 (a1D). In contrast to a1C, a1D Ca channel is highly ex-
pressed in the sinoatrial node and atria, and is involved in the impulse gen-
eration and propagation through the AV node. Deletion of the a1C gene results
in embryonic lethality before E14.5 and there are no pharmacological or bio-
physical means to separate a1D from a1C Ca currents. The aim of this study
